• Info
  • Insider Ownership

Insider Trading & Ownership of CARL L. GORDON

Location
New York, NY
Summary
The estimated net worth of CARL L. GORDON is at least $33,638,698 dollars as of 05 Jan 2026. CARL L. GORDON is the Director of Venetian-1 Acquisition Corp. and owns shares of Lomond Therapeutics Holdings, Inc. stock worth about $10.71M. CARL L. GORDON is the Director, 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $8.11M. CARL L. GORDON is the Director, 10%+ Owner of Terns Pharmaceuticals, Inc. and owns shares of Terns Pharmaceuticals, Inc. (TERN) stock worth about $7.56M. CARL L. GORDON is the Director, 10%+ Owner of ArriVent Biopharma, Inc. and owns shares of ArriVent BioPharma, Inc. (AVBP) stock worth about $5.52M. CARL L. GORDON is the Director, 10%+ Owner of Adicet Bio, Inc. and owns shares of Adicet Bio, Inc. (ACET) stock worth about $941.6K. CARL L. GORDON is the Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $799.8K.
Signature
/s/ Neil Lerner, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when CARL L. GORDON files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of CARL L. GORDON

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
Lomond Therapeutics Holdings, Inc. Director $10,709,024 01 Nov 2024
MBX MBX Biosciences, Inc. Director, 10%+ Owner $8,107,095 +$2,020,756 +33% 14 Feb 2025
TERN Terns Pharmaceuticals, Inc. Director, 10%+ Owner $7,556,350 15 Jul 2024
AVBP ArriVent BioPharma, Inc. Director, 10%+ Owner $5,524,874 30 Jan 2024
ACET Adicet Bio, Inc. Director, 10%+ Owner $941,594 21 Aug 2024
KROS Keros Therapeutics, Inc. Director $799,761 21 Nov 2025
CMPX Compass Therapeutics, Inc. Director $0 -$5,678,571 -100% 02 Jan 2026
KNTE Kinnate Biopharma Inc. Director, 10%+ Owner $0 03 Apr 2024
THRX Theseus Pharmaceuticals, Inc. Director, 10%+ Owner $0 14 Feb 2024
IRON Disc Medicine, Inc. Director, 10%+ Owner 04 Oct 2021
ORIC Oric Pharmaceuticals, Inc. Director, 10%+ Owner 16 Jun 2021

Insider Transactions Reported by CARL L. GORDON:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.